Cargando…

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers

As the COVID-19 pandemic continues to spread, hundreds of new initiatives including studies on existing medicines are running to fight the disease. To deliver a potentially immediate and lasting treatment to current and emerging SARS-CoV-2 variants, new collaborations and ways of sharing are require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riahi, Saleh, Lee, Jae Hyeon, Wei, Shuai, Cost, Robert, Masiero, Alessandro, Prades, Catherine, Olfati-Saber, Reza, Wendt, Maria, Park, Anna, Qiu, Yu, Zhou, Yanfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344454/ https://www.ncbi.nlm.nih.gov/pubmed/34396040 http://dx.doi.org/10.1093/abt/tbab011

Ejemplares similares

Surface ID: a geometry-aware system for protein molecular surface comparison
por: Riahi, Saleh, et al.
Publicado: (2023)

A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies
por: Chen, Xun, et al.
Publicado: (2020)

Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
por: Zhou, Qun, et al.
Publicado: (2021)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
por: Murji, Amyn A., et al.
Publicado: (2021)

Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
por: Alvarenga, Larissa M., et al.
Publicado: (2014)

High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
por: Lücke, Arlen-Celina, et al.
Publicado: (2022)

Engineering highly efficient NIR-II FRET platform for Background-Free homogeneous detection of SARS-CoV-2 neutralizing antibodies in whole blood
por: Zhao, Lei, et al.
Publicado: (2023)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies
por: Sun, Ming, et al.
Publicado: (2016)

Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk
por: Castilla, Joaquin, et al.
Publicado: (1998)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Engineering pan–HIV-1 neutralization potency through multispecific antibody avidity
por: Rujas, Edurne, et al.
Publicado: (2022)

A general Fc engineering platform for the next generation of antibody therapeutics
por: Chen, Da, et al.
Publicado: (2021)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
por: Howell, Katie A., et al.
Publicado: (2017)

DEVELOPMENT OF LABORATORY AND POINT OF CARE DETECTION PLATFORMS FOR COVID-19 NEUTRALIZING ANTIBODIES AND IMMUNE STATUS
por: Trudil, D., et al.
Publicado: (2023)

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
por: Dippel, Andrew, et al.
Publicado: (2022)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Engineering an anti-CD52 antibody for enhanced deamidation stability
por: Qiu, Huawei, et al.
Publicado: (2019)

Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020)

An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
por: Ntumngia, Francis B., et al.
Publicado: (2017)

Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection
por: Slezak, Tomasz, et al.
Publicado: (2021)

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
por: Cortese, Mirko, et al.
Publicado: (2021)

Zika Virus Infection and Antibody Neutralization in FcRn Expressing Placenta and Engineered Cell Lines
por: Xu, Yanqun, et al.
Publicado: (2022)

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
por: Diamant, Eran, et al.
Publicado: (2015)

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
por: Powell, Allison B., et al.
Publicado: (2020)

Effect of Abutment Height on Retention of Single Cement-retained, Wide- and Narrow-platform Implant-supported Restorations
por: Saleh Saber, Fariba, et al.
Publicado: (2012)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization
por: Shinoda, Kaori, et al.
Publicado: (2009)

Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn
por: Gong, Rui, et al.
Publicado: (2012)

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
por: Nahmad, A. D., et al.
Publicado: (2022)

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
por: Zhao, Fangzhu, et al.
Publicado: (2022)

B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection
por: Sun, Caijun, et al.
Publicado: (2023)

Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
por: Metcalf, Matthew C., et al.
Publicado: (2023)

Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals
por: Stelitano, Debora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6ddv3vhjm2bjdjt56tj76hsuj